This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Mark Aspinall-O'Dea, PhD
EMEA Business Development Manager at Retrogenix Ltd.
Speaker

Profile

Mark is responsible for growing Retrogenix’s European and non-North American business portfolio and is based at our UK headquarters in the Peak District. His wide-ranging experience includes 10 years in postdoctoral research, working in both clinical and academic settings. During this period he established positive long-term relationships with key opinion leaders from a range of disciplines through his involvement in international scientific collaborations and consultancy projects in both the public and private sector. Mark is first-author on multiple peer-reviewed publications and has presented his primary research findings at international conferences. Immediately prior to joining Retrogenix, Mark served as Sales Account Manager for Stratech Scientific Limited, covering the whole of the North UK territory. He obtained his PhD in Biochemistry from the University of Sheffield, UK, in 2005.